Bisphosphonic acid derivatives, their production and use
CA 1287350 C · Owner: Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Fabrik Produktionsa Ktieselskab) · Inventors: Binderup, Ernst T.; Liisberg, Sven
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Novel compounds of Formula I (I), or pharmaceutically-acceptable salts thereof or pharma-, ceutically-acceptable in vivo hydrolyzable esters thereof are provided herein. In such Formula, R1-R11 can be the same or different and stand for hydrogen, a straight branched or cyclic, C1-C10 hydrocarbon radical phenyl or a phenyl-C1-C4-alkyl, radical; n is zero or one and m is zero, one or two; or R2 and, R4 when taken together form an unsubstituted saturated aliphatic 5-, 6- or 7- membered ring or a saturated aliphatic 5- 6- or 7-, membered ring which is substituted with one or more C1-C4-alkyl radicals. Such compounds are valuable in human and veterinary practice by reducing bone resorption and …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Granted August 6, 1991. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended August 6, 2008.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.